842 related articles for article (PubMed ID: 17254452)
1. [Change in plasma N-terminal pro-brain natriuretic peptide in children with Kawasaki disease and its value in clinical practice].
Zhang QY; Du JB; Chen YH; Li WZ
Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):886-90. PubMed ID: 17254452
[TBL] [Abstract][Full Text] [Related]
2. Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease.
Kawamura T; Wago M; Kawaguchi H; Tahara M; Yuge M
Pediatr Int; 2000 Jun; 42(3):241-8. PubMed ID: 10881579
[TBL] [Abstract][Full Text] [Related]
3. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
Huiling L; Yaping L; Xiufen H
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507
[TBL] [Abstract][Full Text] [Related]
4. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
[TBL] [Abstract][Full Text] [Related]
5. [Levels of serum brain natriuretic peptide and the correlation to heart function in children with Kawasaki disease].
Sun YP; Wang WD; Zheng XC; Wang JJ; Ma SC; Xu YJ
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Mar; 12(3):169-71. PubMed ID: 20350422
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic value of plasma concentration of pro-brain natriuretic peptide in congestive heart failure in pediatric patients with ventricular septal defects].
Wu YR; Chen SB; Huang MR; Zhang YQ; Sun K; Chen S
Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):161-4. PubMed ID: 15833183
[TBL] [Abstract][Full Text] [Related]
7. Correlation between NT-pro BNP levels and early mitral annulus velocity (E') in patients with non-ST-segment elevation acute coronary syndrome.
Barbosa MM; Nunes Mdo C; Castro LR; Nominato LF; Alencar MC; Ribeiro AL
Echocardiography; 2008 Apr; 25(4):353-9. PubMed ID: 18177379
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant laboratory marker of Kawasaki disease; NT-pro-BNP or hs-CRP?
Cho SY; Kim Y; Cha SH; Suh JT; Han MY; Lee HJ
Ann Clin Lab Sci; 2011; 41(4):360-3. PubMed ID: 22166506
[TBL] [Abstract][Full Text] [Related]
9. B-type natriuretic peptide and N-terminal pro-BNP in the acute phase of Kawasaki disease.
Iwashima S; Ishikawa T
World J Pediatr; 2013 Aug; 9(3):239-44. PubMed ID: 23335186
[TBL] [Abstract][Full Text] [Related]
10. Cardiac function on 3-D speckle tracking imaging and cytokines in Kawasaki disease.
Kato M; Ayusawa M; Watanabe H; Komori A; Abe Y; Nakamura T; Kamiyama H; Takahashi S
Pediatr Int; 2018 Apr; 60(4):342-348. PubMed ID: 29350882
[TBL] [Abstract][Full Text] [Related]
11. Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease.
Reddy M; Singh S; Rawat A; Sharma A; Suri D; Rohit MK
Rheumatol Int; 2016 Apr; 36(4):551-9. PubMed ID: 26849890
[TBL] [Abstract][Full Text] [Related]
12. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with active infective endocarditis.
Kahveci G; Bayrak F; Mutlu B; Bitigen A; Karaahmet T; Sonmez K; Izgi A; Degertekin M; Basaran Y
Am J Cardiol; 2007 May; 99(10):1429-33. PubMed ID: 17493474
[TBL] [Abstract][Full Text] [Related]
14. Serum brain natriuretic peptide in children with Kawasaki disease.
Sun YP; Wei CP; Wang WD; Zheng XC; Wang YJ; Ma SC; Xu YJ
World J Emerg Med; 2010; 1(2):114-7. PubMed ID: 25214952
[TBL] [Abstract][Full Text] [Related]
15. Plasma concentrations of NT-pro-BNP and cardiac troponin-I in relation to doxorubicin-induced cardiomyopathy and cardiac function in childhood malignancy.
Soker M; Kervancioglu M
Saudi Med J; 2005 Aug; 26(8):1197-202. PubMed ID: 16127512
[TBL] [Abstract][Full Text] [Related]
16. Increased plasma type B natriuretic peptide in the acute phase of Kawasaki disease.
Kishimoto S; Suda K; Teramachi Y; Nishino H; Kudo Y; Ishii H; Iemura M; Takahashi T; Okamura H; Matsuishi T
Pediatr Int; 2011 Oct; 53(5):736-741. PubMed ID: 21410593
[TBL] [Abstract][Full Text] [Related]
17. Echocardiographic Parameters During and Beyond Onset of Kawasaki Disease Correlate with Onset Serum N-Terminal pro-Brain Natriuretic Peptide (NT-proBNP).
Desjardins L; Dionne A; Meloche-Dumas L; Fournier A; Dahdah N
Pediatr Cardiol; 2020 Jun; 41(5):947-954. PubMed ID: 32172336
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between heart rate variability and coronary artery lesion in children with Kawasaki disease].
Chen TT; Shi K; Liu YL; Guo YH; Li Y; Wang XM
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jun; 17(6):607-12. PubMed ID: 26108324
[TBL] [Abstract][Full Text] [Related]
19. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
[TBL] [Abstract][Full Text] [Related]
20. Utility of plasma N-terminal brain natriuretic peptide as a marker of functional capacity in patients with chronic severe mitral regurgitation.
Yusoff R; Clayton N; Keevil B; Morris J; Ray S
Am J Cardiol; 2006 May; 97(10):1498-501. PubMed ID: 16679092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
